Hyperfractionated radiation therapy for hypopharyngeal carcinoma compared with conventional radiation therapy: Local control, laryngeal preservation and overall survival

Japanese Journal of Clinical Oncology

Volumn 33, Issue 9, 2003, Pages 450-455

  Niibe, Yuzuru ^a,c   Karasawa, Katsuyuki ^a   Mitsuhashi, Toshio ^a   Tanaka, Yoshiaki ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Conventional fractionation; Hyperfractionation; Hypopharyngeal carcinoma; Laryngeal preservation; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EAR NOSE THROAT SURGERY; FEMALE; HOSPITAL CARE; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; INOPERABLE CANCER; INTERMETHOD COMPARISON; JAPAN; LARYNGECTOMY; LARYNX; MALE; RADIATION DOSE FRACTIONATION; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT REFUSAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; HYPOPHARYNX TUMOR; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNX; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0642372044     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg084     Document Type: Article

References (20)

1. Ang KK. Fractionation effects in clinical practice. In: Leibel SA, Phillips TL, editors. Textbook of Radiation Oncology. Philadelphia: WB Saunders 1998;26-41.
2. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiation therapy for head and neck squamous cell carcinoma: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
3. Horiot JC, Fur LR, N'Guyen T, Chenal C, Schraub S, Alfonsi S, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC Cooperative Group of Radiotherapy. Radiother Oncol 1992;25:231-41.
4. Bataini P, Brugere J, Bernier J, Jaulerry CH, Picot C, Ghossein NA. Results of radical radiotherapeutic treatment of carcinoma of the piriform sinus: Experience of the Institute of Curie. Int J Radiat Oncol Biol Phys 1982;8:1277-86.
5. Dubois JB, Guerrier B, Di Ruggiero JM, Pourquier H. Cancer of the piriform sinus: Treatment by radiation therapy alone and with surgery. Radiology 1986;160:831-6.
6. Marks JE, Smith PG, Sessions DG. Pharyngeal wall cancer: A reappraisal after comparison of treatment methods. Arch Otolaryngol 1985;111:79-85.
7. Wang CC. Carcinoma of the hypopharynx. In: Wang CC, editor. Radiation Therapy for Head and Neck Neoplasms: Indications, Techniques and Results, 2nd ed. Chicago: Year Book Medical Publishers 1990;207-15.
8. International Union Against Cancer. Pharynx. In: Sobin LH, Wittekind CH, editors. TNM Classification of Malignant Tumours. 5th ed. New York: Wiley-Liss, Inc. 1997;25-32.
9. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48. Geneva: WHO 1979.
10. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [Editorial]. Int J Radiat Oncol Biol Phys 1995;31:1341-6.
11. Fletcher GH. Clinical dose-response curves of human malignant epithelial tumours. Br J Radiol 1973;46:1-12.
12. Perez C, Pilepich M, Zivnuska F. Tumor control in definitive irradiation of localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1986;12: 523-32.
13. Hunt MA, Zelefsky MJ, Wolden S, Chui CS, LoSasso T, Tosenzweig CL, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 2001;49:623-32.
14. Nagata Y, Negoro Y, Aoki T, Mizowaki T, Takayama K, Kokubo M, et al. Clinical outcomes of 3D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002;52:1041-6.
15. Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, et al. Computed tomography - guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 2001;51:666-70.
16. Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53:1111-6.
17. Wang CC, Blitzer PH, Suite HD. Twice-a-day radiation therapy for head and neck. Cancer 1985;55:2100-4.
18. Roberts SA, Hendy JH. The delay before onset of accelerated tumor cells repopulation during radiotherapy. A direct maximum-likelihood analysis of a collection of world-wide tumor-control data. Radiother Oncol 1993; 29:69-74.
19. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27: 131-46.
20. Akimoto T, Mitsuhashi N, Sakurai H, Takahashi T, Yamakawa M, Hayakawa K, et al. Results of radiation therapy for hypopharyngeal carcinomas: impact of accelerated hyperfractionation on prognosis. Jpn J Clin Oncol 1996;26:169-74.